English
简体中文
Total: £ 56.28
Published Date: 2025-08-30 | Pages: 81 | Tables: 80 | Pharma & Healthcare
The global market for Aneurysmal Subarachnoid Hemorrhage Drugs was valued at US$ 162 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 2.0% during the forecast period.
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke caused by bleeding in the space surrounding the brain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aneurysmal Subarachnoid Hemorrhage Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aneurysmal Subarachnoid Hemorrhage Drugs.
The Aneurysmal Subarachnoid Hemorrhage Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aneurysmal Subarachnoid Hemorrhage Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Arbor Pharmaceuticals
PDS Biotechnology Corporation
Johnson and Johnson
Mylan N.V
Orexo AB
Pfizer
Purdue Pharma
Pharmaxis
Sun Pharmaceutical Industries
Teva Pharmaceutical
Segment by Type
Opioid Analgesic
Calcium Channel Blocker
Anticonvulsant
Stool Softener
Osmotic Agent
Other Drugs
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aneurysmal Subarachnoid Hemorrhage Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Aneurysmal Subarachnoid Hemorrhage Drugs Market Overview
1.1 Product Definition
1.2 Aneurysmal Subarachnoid Hemorrhage Drugs by Type
1.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Opioid Analgesic
1.2.3 Calcium Channel Blocker
1.2.4 Anticonvulsant
1.2.5 Stool Softener
1.2.6 Osmotic Agent
1.2.7 Other Drugs
1.3 Aneurysmal Subarachnoid Hemorrhage Drugs by Application
1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Estimates and Forecasts
1.4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue 2020-2031
1.4.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales 2020-2031
1.4.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Aneurysmal Subarachnoid Hemorrhage Drugs Market Competition by Manufacturers
2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Aneurysmal Subarachnoid Hemorrhage Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aneurysmal Subarachnoid Hemorrhage Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aneurysmal Subarachnoid Hemorrhage Drugs, Product Type & Application
2.7 Global Key Manufacturers of Aneurysmal Subarachnoid Hemorrhage Drugs, Date of Enter into This Industry
2.8 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Competitive Situation and Trends
2.8.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Aneurysmal Subarachnoid Hemorrhage Drugs Players Market Share by Revenue
2.8.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Scenario by Region
3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region: 2020-2031
3.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region: 2020-2025
3.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region: 2026-2031
3.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region: 2020-2031
3.3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region: 2020-2025
3.3.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region: 2026-2031
3.4 North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Country
3.4.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2020-2031)
3.4.3 North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Country
3.5.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2020-2031)
3.5.3 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Country
3.7.1 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2020-2031)
3.7.3 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2020-2031)
4.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2020-2025)
4.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2026-2031)
4.1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2020-2031)
4.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2020-2031)
4.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2020-2025)
4.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2026-2031)
4.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2020-2031)
5.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2020-2025)
5.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2026-2031)
5.1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2020-2031)
5.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2020-2031)
5.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2020-2025)
5.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2026-2031)
5.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Arbor Pharmaceuticals
6.1.1 Arbor Pharmaceuticals Company Information
6.1.2 Arbor Pharmaceuticals Description and Business Overview
6.1.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.1.5 Arbor Pharmaceuticals Recent Developments/Updates
6.2 PDS Biotechnology Corporation
6.2.1 PDS Biotechnology Corporation Company Information
6.2.2 PDS Biotechnology Corporation Description and Business Overview
6.2.3 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.2.5 PDS Biotechnology Corporation Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Company Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Mylan N.V
6.4.1 Mylan N.V Company Information
6.4.2 Mylan N.V Description and Business Overview
6.4.3 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.4.5 Mylan N.V Recent Developments/Updates
6.5 Orexo AB
6.5.1 Orexo AB Company Information
6.5.2 Orexo AB Description and Business Overview
6.5.3 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.5.5 Orexo AB Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Purdue Pharma
6.7.1 Purdue Pharma Company Information
6.7.2 Purdue Pharma Description and Business Overview
6.7.3 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.7.5 Purdue Pharma Recent Developments/Updates
6.8 Pharmaxis
6.8.1 Pharmaxis Company Information
6.8.2 Pharmaxis Description and Business Overview
6.8.3 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.8.5 Pharmaxis Recent Developments/Updates
6.9 Sun Pharmaceutical Industries
6.9.1 Sun Pharmaceutical Industries Company Information
6.9.2 Sun Pharmaceutical Industries Description and Business Overview
6.9.3 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Company Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Chain Analysis
7.2 Aneurysmal Subarachnoid Hemorrhage Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aneurysmal Subarachnoid Hemorrhage Drugs Production Mode & Process Analysis
7.4 Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Marketing
7.4.1 Aneurysmal Subarachnoid Hemorrhage Drugs Sales Channels
7.4.2 Aneurysmal Subarachnoid Hemorrhage Drugs Distributors
7.5 Aneurysmal Subarachnoid Hemorrhage Drugs Customer Analysis
8 Aneurysmal Subarachnoid Hemorrhage Drugs Market Dynamics
8.1 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Trends
8.2 Aneurysmal Subarachnoid Hemorrhage Drugs Market Drivers
8.3 Aneurysmal Subarachnoid Hemorrhage Drugs Market Challenges
8.4 Aneurysmal Subarachnoid Hemorrhage Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) of Key Manufacturers (2020-2025)
Table 5. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Aneurysmal Subarachnoid Hemorrhage Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Aneurysmal Subarachnoid Hemorrhage Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Aneurysmal Subarachnoid Hemorrhage Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aneurysmal Subarachnoid Hemorrhage Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Aneurysmal Subarachnoid Hemorrhage Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aneurysmal Subarachnoid Hemorrhage Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2020-2025) & (K MT)
Table 18. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2026-2031) & (K MT)
Table 20. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2020-2025) & (K MT)
Table 27. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2026-2031) & (K MT)
Table 28. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2020-2025) & (K MT)
Table 32. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2026-2031) & (K MT)
Table 33. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2020-2025) & (K MT)
Table 37. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2026-2031) & (K MT)
Table 38. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2020-2025) & (K MT)
Table 42. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2026-2031) & (K MT)
Table 43. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2026-2031) & (K MT)
Table 48. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2020-2025)
Table 51. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2026-2031)
Table 52. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Type (2020-2025)
Table 59. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Type (2026-2031)
Table 60. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Application (2020-2025)
Table 61. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Application (2026-2031)
Table 62. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Application (2020-2025)
Table 69. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Application (2026-2031)
Table 70. Arbor Pharmaceuticals Company Information
Table 71. Arbor Pharmaceuticals Description and Business Overview
Table 72. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 74. Arbor Pharmaceuticals Recent Developments/Updates
Table 75. PDS Biotechnology Corporation Company Information
Table 76. PDS Biotechnology Corporation Description and Business Overview
Table 77. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 79. PDS Biotechnology Corporation Recent Developments/Updates
Table 80. Johnson and Johnson Company Information
Table 81. Johnson and Johnson Description and Business Overview
Table 82. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 84. Johnson and Johnson Recent Developments/Updates
Table 85. Mylan N.V Company Information
Table 86. Mylan N.V Description and Business Overview
Table 87. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 89. Mylan N.V Recent Developments/Updates
Table 90. Orexo AB Company Information
Table 91. Orexo AB Description and Business Overview
Table 92. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 94. Orexo AB Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Purdue Pharma Company Information
Table 101. Purdue Pharma Description and Business Overview
Table 102. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 104. Purdue Pharma Recent Developments/Updates
Table 105. Pharmaxis Company Information
Table 106. Pharmaxis Description and Business Overview
Table 107. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 109. Pharmaxis Recent Developments/Updates
Table 110. Sun Pharmaceutical Industries Company Information
Table 111. Sun Pharmaceutical Industries Description and Business Overview
Table 112. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 114. Sun Pharmaceutical Industries Recent Developments/Updates
Table 115. Teva Pharmaceutical Company Information
Table 116. Teva Pharmaceutical Description and Business Overview
Table 117. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 119. Teva Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Aneurysmal Subarachnoid Hemorrhage Drugs Distributors List
Table 123. Aneurysmal Subarachnoid Hemorrhage Drugs Customers List
Table 124. Aneurysmal Subarachnoid Hemorrhage Drugs Market Trends
Table 125. Aneurysmal Subarachnoid Hemorrhage Drugs Market Drivers
Table 126. Aneurysmal Subarachnoid Hemorrhage Drugs Market Challenges
Table 127. Aneurysmal Subarachnoid Hemorrhage Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Aneurysmal Subarachnoid Hemorrhage Drugs
Figure 2. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share by Type: 2024 & 2031
Figure 4. Opioid Analgesic Product Picture
Figure 5. Calcium Channel Blocker Product Picture
Figure 6. Anticonvulsant Product Picture
Figure 7. Stool Softener Product Picture
Figure 8. Osmotic Agent Product Picture
Figure 9. Other Drugs Product Picture
Figure 10. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size (2020-2031) & (US$ Million)
Figure 17. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (2020-2031) & (K MT)
Figure 18. Global Aneurysmal Subarachnoid Hemorrhage Drugs Average Price (USD/MT) & (2020-2031)
Figure 19. Aneurysmal Subarachnoid Hemorrhage Drugs Report Years Considered
Figure 20. Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Manufacturers in 2024
Figure 21. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Aneurysmal Subarachnoid Hemorrhage Drugs Players: Market Share by Revenue in Aneurysmal Subarachnoid Hemorrhage Drugs in 2024
Figure 23. Aneurysmal Subarachnoid Hemorrhage Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country (2020-2031)
Figure 26. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country (2020-2031)
Figure 30. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country (2020-2031)
Figure 31. Germany Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region (2020-2031)
Figure 38. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country (2020-2031)
Figure 49. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. U.A.E Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Aneurysmal Subarachnoid Hemorrhage Drugs by Type (2020-2031)
Figure 59. Global Revenue Market Share of Aneurysmal Subarachnoid Hemorrhage Drugs by Type (2020-2031)
Figure 60. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Type (2020-2031)
Figure 61. Global Sales Market Share of Aneurysmal Subarachnoid Hemorrhage Drugs by Application (2020-2031)
Figure 62. Global Revenue Market Share of Aneurysmal Subarachnoid Hemorrhage Drugs by Application (2020-2031)
Figure 63. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Application (2020-2031)
Figure 64. Aneurysmal Subarachnoid Hemorrhage Drugs Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
